Keyphrases
Alpha Dose
28%
Anemia Management
28%
Background Change
14%
Claims Data
14%
Dialysis Facility
42%
Dialysis Patients
100%
Dose Rate
14%
Epoetin Alfa
57%
Erythropoiesis-stimulating Agents
14%
Exposure Level
14%
Facility Level
100%
Hemodialysis Patients
14%
Hemoglobin Concentration
100%
Hemoglobin Estimation
14%
Hemoglobin Level
100%
High Prevalence
14%
Intravenous Iron
14%
Iron Dose
42%
Iron Oxide
14%
Maintenance Hemodialysis Patients
14%
Management Practices
14%
Management Trends
14%
Medicare
14%
Medicare Reimbursement
14%
Patient Mix
14%
Patient Risk
100%
Patient-level
28%
Primary Payer
14%
Red Blood Cell Transfusion
71%
Relative Risk
14%
Retrospective Follow-up
14%
Risk Analysis
14%
Small Units
14%
Transfusion
14%
Transfusion Rate
71%
Transfusion Risks
100%
Treatment Practices
14%
Medicine and Dentistry
Anemia
40%
Case Mix
20%
Erythrocyte Transfusion
100%
Hematinic
20%
Hemodialysis
40%
Hemoglobin Determination
100%
Iron
60%
Medicare
40%
Prevalence
20%
Recombinant Erythropoietin
80%
Nursing and Health Professions
Anemia
28%
Antianemic Agent
14%
Case Mix
14%
Erythrocyte Transfusion
71%
Hemodialysis
28%
Hemoglobin Blood Level
100%
Hemoglobin Determination
100%
Iron
42%
Medicare
28%
Prevalence
14%
Procrit
57%
Treatment Outcome
14%
Pharmacology, Toxicology and Pharmaceutical Science
Anemia
50%
Antianemic Agent
25%
Case Mix
25%
Hemodialysis
50%
Iron
75%
Prevalence
25%
Recombinant Erythropoietin
100%